Abstract In the early-to-mid 1960s, there was considerable use of LSD in psychotherapy in several countries. However, its use gradually levelled off. Two explanations have been suggested: The first revolves around a ‘moral panic’ in the wake of the introduction of cannabis and LSD by subcultural youth groups. The second focuses on the lack of proof for the therapeutic efficacy of LSD at a time...
We are now witnessing a radical revival in clinical research on the use of psychedelics (e.g. LSD and psilocybin), where ‘mystical’ experiences are at the centre. Drawing on in-depth interviews with 50 psychedelic drug users, we document how they draw on archetypical mystical narratives, comprising three key dimensions: (1) the transcendence of time and space; (2) deep euphoria; and (3) the...
We study the significance of stories about bad trips among users of psychedelics. Drawing on narrative theory, we describe the characteristics of such stories and explore the work they do. In-depth qualitative interviews with 50 Norwegian users of psychedelics. Almost all participants had frightening experiences when using psychedelics and many described these as bad trips. The key feature of a...
Ecstasy pills with MDMA as the main ingredient were introduced in many European countries in the 1980s, and were often linked to the rave and club scenes. However, use gradually levelled off, in part as a response to increased concerns about possible mental health consequences and fatalities. Extensive use of MDMA now seems to be re-emerging in many countries. In this study, we investigated the...